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experiment (Watts and Rees, 1977) suggests that differential attrition from the experimental and control groups of both black and Spanishspeaking minorities could account for differences otherwise attributable to the intervention. Likewise, Wortman (1978) has argued that the process of differential attrition was a plausible explanation of the negative effects found in McCord's (1978) 30-year follow-up of the relationship of counseling to subsequent delinquency in a randomized controlled trial.
As a result of this differential attrition process, a well-conceived randomized experimental design may drift toward a quasi-experimental design model with all of its inferential limitations (see, for example, Special Report, 1982) . Despite the creative application of statistical procedures to adjust for the resulting nonequivalence between groups (Kenny, 1975; Magidson, 1977; Reichardt, 1979) , there is no satisfactory statistical solution to the lack of adherence to the original design protocol.
The most common recommendation of methodologists is to analyze the data from randomized experiments according to the original assignment (Riecken and Boruch, 1974) or &dquo;intention to treat&dquo; (Peto et al., 1976) . This approach is a tradeoff that preserves the design at the expense of a biased estimate of the treatment effect.
THE PROBLEM OF CROSSOVERS
In the assessment of medical technologies, researchers will often confront situations in which specific techniques are preferred by patients due to their association with secondary outcomes that are intrinsically desirable. In instances such as these, it will be particularly difficult to maintain the design protocol. This precise situation confronts researchers interested in the evaluation of the potential benefits of coronary artery bypass graft surgery (CABGS) for patients with coronary heart disease (Wortman, 1981) .
Given the consistent finding that angina is relieved in patients receiving surgery (Special Report, 1981) (Wortman, 1981) .
In fact, the most common biostatistical research practice is to consider crossovers as an endpoint, that is, as no longer in the study, at the time they receive surgery. This would bring the medical group survival rate closer to that for the surgical group, if one assumes that surgery is beneficial, an assumption consistent with the data. Consequently, the crossover problem will underestimate any potential benefit due to surgery. If one follows the recommendation to include crossovers in their originally assigned group, then the effectiveness of surgery will also be underestimated (again assuming it is beneficial).
Neither method then can overcome the effects of differential attrition and treatment diffusion to produce an unbiased estimate of effect.
The worst case approach uses a general strategy of determining the maximum degree of influence attributable to a particular factor and thus the factor's likelihood of contributing to the difference obtained. In this way it resembles the sensitivity analysis used by economists in cost-effectiveness and cost-benefit analyses (Weinstein and Stason, 1982) Measures of effect size (Glass, McGaw, and Smith, 1981) (10)), thus allowing the researcher to conclude that the difference between medical and surgical groups would be underestimated by a maximum of 3.6 percentage points as a result of crossovers, assuming that the mean in the surgical group is greater than the mean in the medical group. While in the case of attrition due to crossovers it is obvious that an adjustment must be made in the control group measure, the practice is consistent with the identification of distortion in research that uses historical (Sachs, Chalmers, and Smith, 1982) and other nonrandomized controls (Meier, 1978) .
GENERAL COMMENTS
These findings suggest that high crossover rates can substantially increase the mean of the distribution of the control group of medical patients in which crossovers have been eliminated. Consequently, the benefit attributable to surgery would be substantially underestimated in controlled trials of CABGS. While from a statistical point of view mean shifts between 20% and 50% would be considered between small and medium effect sizes (Cohen, 1977) , innovative surgeries typically produce modest benefits (Gilbert, McPeek, and Mosteller, 1977) that assume importance through their implementation with large groups of patients. For example, the evidence from randomized controlled trials suggests a benefit of CABGS of less than 5% (Wortman and Yeaton, 1983 Despite the shortcomings associated with idealized data, the relationship between crossover rates and survival presented in this report will allow researchers to estimate more accurately the potential influence of crossovers, and thus to improve the quality of their inferences. Given the uncertainties in interpreting the results from flawed research studies, it is important that investigators acknowledge the potential bias caused by such &dquo;threats to validity&dquo; (Campbell and Stanley, 1966 
